For patients with end-stage renal disease (ESRD), kidney transplantation (KT) offers an opportunity to increase both patient survival (PS) and health-related quality of life in all age groups.
| INTRODUC TI ON
For patients with end-stage renal disease (ESRD), kidney transplantation (KT) offers an opportunity to increase both patient survival (PS) and health-related quality of life in all age groups. 1, 2 In case of children and adolescents, however, the transfer of care from a pediatric to an adult hospital poses a time of elevated risk for graft loss and patients being lost to follow-up. 3, 4 To tackle this critical phase, the concept of transition, the planned process of transferring care, was introduced 25 years ago. 5 Since then, some promising evidence of better outcomes has been published. 6 Most literature on the topic of transition is, however, based on clinical experience and expert opinions instead of actual scientific research.
Early literature regarded adolescents as a high-risk group for noncompliance 4 but this terminology soon evolved to non-adherence. Studies in neuroimaging show that complex reasoning and the ability to comprehend causal relationships are the last processes to mature during the third decade of life. 7, 8 With the advancements of research in brain development and adolescent medicine, incorporating and accepting a chronic condition as a part of the developing personality can be seen as a significant additional task for adolescents who are simultaneously attempting to achieve educational goals and financial independence. As a sign of understanding these developmental tasks, the recommendations on transition of care state that transition planning should start early and timing of the transfer of care should be individualized and take into consideration also the at 10 years were similar before and after the implementation of the TM (PS 85% and 90% respectively, P = 0.626; GS 60% and 58%, respectively, P = 0.656). GS was lower in patients transplanted at age 10-18 than in patients transplanted at a younger age in the TM cohort (79% vs 95%, P < 0.001). During the first five years after transfer, 63% of patients had stable KT function, 13% had deteriorating function and 24% lost their KT. Altogether 32 out of 132 patients lost their kidney allograft within five years after transfer to adult care (13 before and 19 after TM implementation, P = 0.566).
The implementation of this TM had no effect on PS or GS. Further measures to improve our TM are in progress.
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adolescents, kidney transplantation, survival, transition, young adults educational and vocational status of each young patient. The aim of this study is to assess the effects of the transition model on patient outcomes in Finnish KT recipients.
| MATERIAL S AND ME THODS

| Patient cohort
Between November 1986 to January 2012, 239 children received a KT in Finland. All patients were transplanted at the Helsinki University Hospital. Patients were followed at their local hospital and also at least once annually at the Helsinki Children's Hospital.
From this cohort, 132 adolescents have transferred from pediatric to adult care and they constitute the study cohort. Two patients (1.5%) have moved abroad but no other patients are lost to follow-up. 
| Transition model
| Data collection
We recovered the following data from the Finnish Registry of Kidney 
| Statistical methods
| Ethics
The Ethics Committee of the Helsinki University Hospital approved the use of patient information and the study protocol (HUS/214/2016).
| RE SULTS
| Demographics
Altogether 132 young patients (69% males) were transferred to adult care and followed for a median of 9.1 years (SD 5.5; Table 1 (Table 1 ). Figure 1 represents the flowchart of patients after transfer to adult services.
| Graft and patient survival
Graft survival rates at 5, 10, and 15 years were 94%, 87%, and 71%, respectively. Patients who received a KT before age 10 had significantly better GS than patients who underwent KT at an older age (95% vs 79%, P < 0.001), as shown in Figure 2 . GS was unaffected by gender (P = 0.693). In total, 55 of the transitioned patients (42%) lost their KT, with 32 events occurring within 5 years after the transfer of care (13 before and 19 after TM implementation, P = 0.566). The overall PS rate was 89%. Nine patients (7%) died with a functioning graft and another five patients (4%) died after returning to dialysis. Mean age at death was 28 years (range, 18-32 years). Causes of death were cardiovascular disease (n = 3), malignancy (n = 2), intoxication (n = 2), infection (n = 2), stroke (n = 2), uremia (n = 1), trauma (n = 1) and one death was undetermined. During the first five years after transfer of care, seven patients died: three in the historical cohort (6%), all of whom had returned to dialysis; and four in the TM cohort (5%), including one on dialysis and three with a functioning graft. The only significant difference between these three subgroups was serum creatinine concentration at transfer, as shown in Table 2 . In the regression analyses, the only significant predictive factor of GS was serum creatinine at transfer, with an increase in risk of graft loss of 1% per each creatinine unit (P < 0.001). Overall PS and GS were similar before and after the implementation of the TM: (PS at 10 years 85% and 90%, respectively, P = 0.626; and GS at 10 years 60% and 58%, respectively P = 0.656; Figure 4 ).
| KT function before and after transfer in relation to the TM
| D ISCUSS I ON
This national, retrospective study assessed the outcomes of young KT patients before and after the implementation of a TM. Although Under 10 years
Age at transplantation
Over 10 years the TM at our center was built to follow international recommendations, 9,11 no significant difference was found in PS and GS rates before and after the implementation of the TM.
We acknowledge several possible explanations for the apparent failure of the TM. Alarmingly, 32 out of 132 grafts (24%) were lost during the first five years following transfer of care. The only significant variable associated with graft loss during this short period was creatinine concentration at transfer which implies that some patients' KTs were already deteriorating at that time. It is also possible that the TM was applied inconsistently or that some aspects important to adolescents' wellbeing were overlooked when designing the TM. The latter seems improbable, however, considering the many issues already taken into consideration, including transition preparations beginning at age 13-14 years, the engagement of a multidisciplinary team, the individualized time of transfer and follow-up in adult services involving mainly the same professionals at least during adolescence and fulfilling the key elements recognized by international experts in the field. 12 However, the consistency of TM implementation was impossible to decipher retrospectively from the data available. Our negative finding may also be due to technical issues. Prior to the TM, both PS and GS rates already exceeded internationally reported rates for this age group. 13 In our study, overall GS at 10 years was 87%. Consequently, very large study populations would be required to demonstrate a statistically significant Internationally, mainly pediatricians have strived to enhance transition of care programs and few adult nephrologists have been involved. 15 This is especially concerning since graft losses peak in adolescence both during and after the transition of care irrespective of the age at KT. 16 A fully integrated transition model may only be achievable in countries with a nationalized healthcare system where, for example, insurance status plays no role. The phenomenon of apparent self-neglect among adolescents may in part be due to the sequence of brain development where causal relationships and impulse control are the last to mature. 8 Other possible explanations may include the way in which adolescents' healthcare needs, developmental stage and limited experience of navigating the healthcare system have often been disregarded in adult care. Receiving a KT during adolescence has been shown to be a risk factor for graft loss. 17 Adolescents with a chronic condition often mature later than their peers and KT recipients often have neuropsychological impairments that may require consideration even after legal maturity. 18 The strengths of this study include the long follow-up, population-based patient cohorts and extremely low rate of patients lost to follow-up (1.5%). Retrospective data collection is a wellknown limitation of all registry-based studies. Transition programs are currently considered the standard of care in pediatrics. Thus, we found the comparison to a historical cohort to be the only feasible method of assessing the effectiveness or our TM. Another problem with a historical comparison is that many changes have occurred in the treatment and follow-up of KT patients, including immunosuppressive medications choice and through target levels, use of antivirals and donor-specific antibodies monitoring.
Unfortunately, we do not have these data but the immunological risk profile between both cohorts was similar. Hypothetically, the TM cohort benefited from modern treatment, which should have increased the apparent effectiveness of our TM. Considering our negative findings, these confounders are likely to be insignificant.
Another problem with the historical comparison was that patients in the TM cohort were younger at KT and consequently had longer follow-up prior to the transfer of care than patients transferred before the implementation of the TM. Although the TM cohort patients were more often diagnosed with congenital nephrosis of the Finnish type than the historical cohort, thus explaining the difference in age and length of follow-up, these differences may also have diluted the possible positive effects of the TM. The long-term prognosis of these patients after KT is similar to those with a different etiology. 19 While the use of registry data assured the comprehensiveness of the reported data, it also limited the amount of variables available for analyses. Information on, for example, minor developmental delays or educational and employment outcomes were unavailable to us. In addition, one major limitation was that we were unable to assess how precisely the TM was implemented in each case.
Improved survival rates are a fairly rough measure of transition success. A recent international, interdisciplinary Delphi study concluded that to define transition as successful also measures of quality of life, attendance at medical appointments and avoidance of emergency visits and unplanned hospitalizations should be included. 20 In the future, these dimensions of transition success should be gathered routinely in addition to survival rates. In an era of personalized medicine, our strategy to improve the TM is to develop preventive measures and treatments tailored according to adolescents' needs, while taking into account also somatic, socioeconomic, and neuropsychological maturation. One of our approaches after 2012 has been the organization of a multidisciplinary event called "Transition camp." This two-day event is offered to patients aged 16-18 and it includes talks with doctors, nurses, and connecting with other young people living with a chronic condition.
Another aim is to develop our follow-up protocol after the transfer of care into a more holistic direction for at least the first three years, while also individualizing the level of support required. In addition, a website has been launched in 2017, with educational material for adolescents, parents, and friends as well as professionals. The effectiveness of this e-health approach remains to be analyzed in the near future. We are committed to improve the treatment pathways of young KT recipients. After all, a successful TM could potentially enhance the cost-benefit of care in addition to the improvements in health and social outcomes.
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